Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

DNA priming and gp120 boosting induces HIV-specific antibodies in a randomized clinical trial.

Rouphael NG, Morgan C, Li SS, Jensen R, Sanchez B, Karuna S, Swann E, Sobieszczyk ME, Frank I, Wilson GJ, Tieu HV, Maenza J, Norwood A, Kobie J, Sinangil F, Pantaleo G, Ding S, McElrath MJ, De Rosa SC, Montefiori DC, Ferrari G, Tomaras GD, Keefer MC; HVTN 105 Protocol Team and the NIAID HIV Vaccine Trials Network.

J Clin Invest. 2019 Sep 30. pii: 128699. doi: 10.1172/JCI128699. [Epub ahead of print]

2.

Phase Ib Trial To Evaluate the Safety and Pharmacokinetics of Multiple Ascending Doses of Filociclovir (MBX-400, Cyclopropavir) in Healthy Volunteers.

Rouphael NG, Hurwitz SJ, Hart M, Beck A, Anderson EJ, Deye G, Osborn B, Cai SY, Focht C, Amegashie C, Bowlin TL, Brooks J, Mulligan MJ.

Antimicrob Agents Chemother. 2019 Aug 23;63(9). pii: e00717-19. doi: 10.1128/AAC.00717-19. Print 2019 Sep.

PMID:
31285228
3.

Streptococcus mitis Expressing Pneumococcal Serotype 1 Capsule.

Lessa FC, Milucky J, Rouphael NG, Bennett NM, Talbot HK, Harrison LH, Farley MM, Walston J, Pimenta F, Gertz RE, Rajam G, Carvalho MDG, Beall B, Whitney CG.

Sci Rep. 2018 Dec 19;8(1):17959. doi: 10.1038/s41598-018-35921-3.

4.

Swimming with the Pigs: A Case of Severe Soft Tissue Infection during a Caribbean Vacation.

Dretler AW, Jacob JT, Rouphael NG.

Case Rep Infect Dis. 2018 Oct 24;2018:4092609. doi: 10.1155/2018/4092609. eCollection 2018.

5.

Reply letter to "Fatal meningococcemia due to Neisseria meningitidis serogroup Y in a vaccinated child receiving eculizumab".

Dretler AW, Rouphael NG, Stephens DS.

Hum Vaccin Immunother. 2018;14(11):2803-2804. doi: 10.1080/21645515.2018.1491247. Epub 2018 Jul 16. No abstract available.

6.

Progress toward the global control of Neisseria meningitidis: 21st century vaccines, current guidelines, and challenges for future vaccine development.

Dretler AW, Rouphael NG, Stephens DS.

Hum Vaccin Immunother. 2018 May 4;14(5):1146-1160. doi: 10.1080/21645515.2018.1451810. Epub 2018 May 9. Review.

7.

Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine.

Levin MJ, Cai GY, Lee KS, Rouphael NG, Mehta AK, Canniff J, Mulligan MJ, Weinberg A.

J Infect Dis. 2018 Mar 13;217(7):1055-1059. doi: 10.1093/infdis/jix653.

8.

Diagnostic Importance of Hyphae on Heart Valve Tissue in Histoplasma Endocarditis and Treatment With Isavuconazole.

Wiley Z, Woodworth MH, Jacob JT, Lockhart SR, Rouphael NG, Gullett JC, Guarner J, Workowski K.

Open Forum Infect Dis. 2017 Nov 24;4(4):ofx241. doi: 10.1093/ofid/ofx241. eCollection 2017 Fall.

9.

Safety, tolerability, and immunogenicity of two Zika virus DNA vaccine candidates in healthy adults: randomised, open-label, phase 1 clinical trials.

Gaudinski MR, Houser KV, Morabito KM, Hu Z, Yamshchikov G, Rothwell RS, Berkowitz N, Mendoza F, Saunders JG, Novik L, Hendel CS, Holman LA, Gordon IJ, Cox JH, Edupuganti S, McArthur MA, Rouphael NG, Lyke KE, Cummings GE, Sitar S, Bailer RT, Foreman BM, Burgomaster K, Pelc RS, Gordon DN, DeMaso CR, Dowd KA, Laurencot C, Schwartz RM, Mascola JR, Graham BS, Pierson TC, Ledgerwood JE, Chen GL; VRC 319; VRC 320 study teams.

Lancet. 2018 Feb 10;391(10120):552-562. doi: 10.1016/S0140-6736(17)33105-7. Epub 2017 Dec 5.

10.

Microneedle patch for immunization of immunocompromised hosts.

Rouphael NG, Mulligan MJ.

Oncotarget. 2017 Oct 25;8(55):93311-93312. doi: 10.18632/oncotarget.22072. eCollection 2017 Nov 7. No abstract available.

11.

The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial.

Rouphael NG, Paine M, Mosley R, Henry S, McAllister DV, Kalluri H, Pewin W, Frew PM, Yu T, Thornburg NJ, Kabbani S, Lai L, Vassilieva EV, Skountzou I, Compans RW, Mulligan MJ, Prausnitz MR; TIV-MNP 2015 Study Group.

Lancet. 2017 Aug 12;390(10095):649-658. doi: 10.1016/S0140-6736(17)30575-5. Epub 2017 Jun 27.

12.

Safety and Immunogenicity of a Recombinant Adenovirus Serotype 35-Vectored HIV-1 Vaccine in Adenovirus Serotype 5 Seronegative and Seropositive Individuals.

Fuchs JD, Bart PA, Frahm N, Morgan C, Gilbert PB, Kochar N, DeRosa SC, Tomaras GD, Wagner TM, Baden LR, Koblin BA, Rouphael NG, Kalams SA, Keefer MC, Goepfert PA, Sobieszczyk ME, Mayer KH, Swann E, Liao HX, Haynes BF, Graham BS, McElrath MJ; NIAID HIV Vaccine Trials Network.

J AIDS Clin Res. 2015 May;6(5). pii: 461. Epub 2015 May 23.

13.

Safety and Immunogenicity of a Subvirion Monovalent Unadjuvanted Inactivated Influenza A(H3N2) Variant Vaccine in Healthy Persons ≥18 Years Old.

Keitel WA, Jackson LA, Edupuganti S, Winokur PL, Mulligan MJ, Thornburg NJ, Patel SM, Rouphael NG, Lai L, Bangaru S, McNeal MM, Bellamy AR, Hill HR; VTEU H3N2v Vaccine Study Work Group.

J Infect Dis. 2015 Aug 15;212(4):552-61. doi: 10.1093/infdis/jiv056. Epub 2015 Feb 3.

14.

Phase II trial in adults of concurrent or sequential 2009 pandemic H1N1 and 2009-2010 seasonal trivalent influenza vaccinations.

Frey SE, Bernstein DI, Brady RC, Keitel WA, El Sahly H, Rouphael NG, Mulligan MJ, Atmar RL, Edupuganti S, Patel SM, Dickey M, Graham I, Anderson EL, Noah DL, Hill H, Wolff M, Belshe RB.

Vaccine. 2015 Jan 1;33(1):163-73. doi: 10.1016/j.vaccine.2014.10.083. Epub 2014 Nov 11.

15.

Strategies to increase responsiveness to hepatitis B vaccination in adults with HIV-1.

Whitaker JA, Rouphael NG, Edupuganti S, Lai L, Mulligan MJ.

Lancet Infect Dis. 2012 Dec;12(12):966-76. doi: 10.1016/S1473-3099(12)70243-8. Review.

16.

Neisseria meningitidis: biology, microbiology, and epidemiology.

Rouphael NG, Stephens DS.

Methods Mol Biol. 2012;799:1-20. doi: 10.1007/978-1-61779-346-2_1. Review.

17.

Cytomegalovirus prostatitis in a heart transplant recipient.

Rouphael NG, Laskar SR, Smith A, Lyon GM.

Am J Transplant. 2011 Jun;11(6):1330-3. doi: 10.1111/j.1600-6143.2011.03519.x. Epub 2011 Apr 12.

18.

Evaluation of serum bactericidal antibody assays for Haemophilus influenzae serotype a.

Rouphael NG, Satola S, Farley MM, Rudolph K, Schmidt DS, Gomez-de-León P, Robbins JB, Schneerson R, Carlone GM, Romero-Steiner S.

Clin Vaccine Immunol. 2011 Feb;18(2):243-7. doi: 10.1128/CVI.00219-10. Epub 2010 Dec 22.

19.

A real-time polymerase chain reaction for the detection of Streptococcus pneumoniae in blood using a mouse model: a potential new "gold standard".

Rouphael NG, Atwell-Melnick N, Longo D, Whaley M, Carlone GM, Sampson JS, Ades EW.

Diagn Microbiol Infect Dis. 2008 Sep;62(1):23-5. doi: 10.1016/j.diagmicrobio.2008.06.002. Epub 2008 Jul 14.

PMID:
18621498
20.

Evolution.

Talati NJ, Rouphael NG.

Am J Med. 2008 Jul;121(7):583-5. doi: 10.1016/j.amjmed.2008.04.007. No abstract available.

PMID:
18589054
21.

Clostridium difficile-associated diarrhea: an emerging threat to pregnant women.

Rouphael NG, O'Donnell JA, Bhatnagar J, Lewis F, Polgreen PM, Beekmann S, Guarner J, Killgore GE, Coffman B, Campbell J, Zaki SR, McDonald LC.

Am J Obstet Gynecol. 2008 Jun;198(6):635.e1-6. doi: 10.1016/j.ajog.2008.01.062. Epub 2008 Apr 8.

PMID:
18395693
22.

Infections associated with haemophagocytic syndrome.

Rouphael NG, Talati NJ, Vaughan C, Cunningham K, Moreira R, Gould C.

Lancet Infect Dis. 2007 Dec;7(12):814-22. Review.

PMID:
18045564
23.

A painful thorn in the foot: a case of eumycetoma.

Rouphael NG, Talati NJ, Franco-Paredes C.

Am J Med Sci. 2007 Aug;334(2):142-4.

PMID:
17700208
24.

Hepatitis B reverse seroconversion in HIV-positive patients: case series and review of the literature.

Rouphael NG, Talati NJ, Rimland D.

AIDS. 2007 Mar 30;21(6):771-4. Review.

PMID:
17413702
25.

Polymyxin B and doxycycline use in patients with multidrug-resistant Acinetobacter baumannii infections in the intensive care unit.

Holloway KP, Rouphael NG, Wells JB, King MD, Blumberg HM.

Ann Pharmacother. 2006 Nov;40(11):1939-45. Epub 2006 Oct 3.

PMID:
17018688
26.

Skin ulcers misdiagnosed as pyoderma gangrenosum.

Rouphael NG, Ayoub NM, Tomb RR.

N Engl J Med. 2003 Mar 13;348(11):1064-6; author reply 1064-6. No abstract available.

PMID:
12637622

Supplemental Content

Loading ...
Support Center